Direct oral anticoagulants and oesophageal disorders: a pharmacovigilance analysis.

Authors

• Mattison, Donald, Mattison D, School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.; Risk Sciences International, Hilton Head Island, SC, USA.

• Gravel, Christopher, Gravel C, School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.; Risk Sciences International, Ottawa, ON, Canada.; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada.

• Krewski, Daniel, Krewski D, School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.; Risk Sciences International, Ottawa, ON, Canada.; McLaughlin Center for Population Health Risk Assessment, University of Ottawa, Ottawa, ON, Canada.

• Azoulay, Laurent, Azoulay L, Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada.; Centre for Clinical Epidemiology, Lady Davis Institute, 3755 Cote Ste-Catherine, H-492, Montreal, QC, H3T 1E2, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, Canada.

• Hicks, Blanaid, Hicks B, Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, UK.

• Douros, Antonios, Douros A, Centre for Clinical Epidemiology, Lady Davis Institute, 3755 Cote Ste-Catherine, H-492, Montreal, QC, H3T 1E2, Canada. antonios.douros@mcgill.ca.; Department of Medicine, McGill University, Montreal, QC, Canada. antonios.douros@mcgill.ca.; Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Berlin, Germany. antonios.douros@mcgill.ca.